Kyverna Therapeutics, Inc. (Nasdaq: KYTX), a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases, today announced updated data from ...

Veteran newsreader John Stapleton, who worked for Good Morning Britain and Channel 4's Breakfast, has died at the age of 79 ...

There’s a good chance that you haven’t heard about a rare condition called chromhidrosis. In a nutshell, the person afflicted with the disease produces colored sweat, from yellow to green, even red ...

John Stapleton has died. The esteemed broadcaster-and-journalist - who had Parkinson's disease complicated by pneumonia - ...

Explore practical implications of new research in nephrotic syndrome, from renal biopsy and genetic testing to managing ...

After decades of trials into pathways that ultimately failed in Sjögren’s disease, recent efforts targeting B cells have ...

I am a 78-year-old male who is in pretty good health. I keep my blood pressure under control and exercise five days a week at a gym, ...

The INTREPID study group, a team of 49 researchers from 30 academic and medical institutions, reports on sustained five-year ...

For decades, multiple sclerosis (MS) research has focused largely on the inflammatory lesions visible on MRI scans. Yet new ...

Of the 209 patients with tardive dyskinesia (TD) that were surveyed, >94% reported movement improvement once treated with AUSTEDO XR® (deutetrabenazine) extended-release tabletsPatients reported high ...

The 10 early signs of Parkinson’s you might not know about - Initial signs can include stiffness, losing your sense of smell and smaller handwriting ...